What is the biggest myth about HRT?

That it's a flat, one-size-fits-all cancer and heart-disease risk for every woman at every age. The evidence shows risk depends heavily on the type of hormone therapy, the route, and especially the age and timing at which you start.

Does HRT cause breast cancer?

Some regimens, mainly long-term combined estrogen-progestin, are linked to a small increase in breast cancer risk in some studies. Estrogen-alone therapy has shown a different picture in research. It's a real risk factor to discuss, not a guaranteed outcome.

Why did doctors stop prescribing HRT in 2002?

The Women's Health Initiative trial was stopped early that year after early results suggested increased risks of breast cancer, heart disease, and stroke. Hormone therapy use dropped sharply within a year as a result, before later research clarified that those risks were tied heavily to the older age of the study population.

The HRT myths still holding women back

Written and edited by the Peryla team. Last reviewed August 2026. Educational information, not medical advice.

Several widely repeated ideas about hormone therapy - that it inevitably causes breast cancer, that it's dangerous for every heart, that you must stop it at a fixed age - trace back to a single, misapplied 2002 study and haven't kept pace with two decades of follow-up research. The FDA's 2025-2026 label changes were a direct response to that gap.

None of this means HRT is risk-free. It means the old blanket warnings overstated risk for the women who actually take hormone therapy today, and the honest picture is more specific than either "totally safe" or "too dangerous."

Myth: HRT causes breast cancer

The reality is more nuanced. Combined estrogen-progestin therapy used for many years is associated with a small increase in breast cancer risk in some studies, roughly comparable to other lifestyle factors like moderate alcohol use or being overweight. Estrogen-alone therapy, used by women without a uterus, has shown a different picture in some research, including no increase or even a reduced risk in certain studies. The FDA's 2025-2026 labeling changes reflect this more precise picture rather than the older blanket cancer warning.

Myth: hormones are dangerous for the heart

This is the myth most directly overturned by the timing hypothesis. In the original WHI cohort, average age 63, cardiovascular risk did rise with hormone therapy. But in women who start therapy under 60 or within 10 years of menopause, research has found neutral or even favorable cardiovascular effects. Age and timing at initiation, not hormone therapy itself, appear to be the deciding factor.

Myth: you must stop HRT at a fixed age

There is no universal expiration date, like 65, written into current guidance. Duration of use is now considered an individual decision based on ongoing symptoms, personal risk factors, and periodic reassessment with a doctor, not a fixed calendar rule. Some women use hormone therapy for a few years around menopause; others continue longer under medical supervision.

Why the myths stuck around so long

The 2002 WHI headlines were widely covered and hormone therapy use dropped by more than half within a year. Medical guidance and training took years to catch up with the re-analyses that followed, and the FDA's own boxed warning language wasn't formally updated until the 2025 expert panel and the resulting 2025-2026 label changes. That's a two-decade lag between updated science and updated regulation, which is a big part of why these myths are still so common.

The 2002 WHI trial studied an average age of 63, over a decade past typical menopause, using an older hormone formulation.
Re-analyses through the 2010s and 2020s established the timing hypothesis, showing risk depends heavily on age at start.
The FDA's expert panel met July 2025; the boxed warning removal was announced November 2025; the first finalized labels were approved February 2026.

When to see a doctor

You stopped or avoided HRT years ago based on the old warnings and want to know if your situation looks different under current guidance.
You have a personal or family history of breast cancer, blood clots, or heart disease - these still need individual review no matter what the general research shows.

Frequently asked questions

What is the biggest myth about HRT?: That it's a flat, one-size-fits-all cancer and heart-disease risk for every woman at every age. The evidence shows risk depends heavily on the type of hormone therapy, the route, and especially the age and timing at which you start.
Does HRT cause breast cancer?: Some regimens, mainly long-term combined estrogen-progestin, are linked to a small increase in breast cancer risk in some studies. Estrogen-alone therapy has shown a different picture in research. It's a real risk factor to discuss, not a guaranteed outcome.
Why did doctors stop prescribing HRT in 2002?: The Women's Health Initiative trial was stopped early that year after early results suggested increased risks of breast cancer, heart disease, and stroke. Hormone therapy use dropped sharply within a year as a result, before later research clarified that those risks were tied heavily to the older age of the study population.